中文版 | English

在结果中检索

CASIA OpenIR

浏览/检索结果: 共52条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Application of Epithelial Growth Factor Receptor-Targeted Magnetic Resonance Imaging and Near-Infrared II Dual-Modal Probe in Lung Cancer Diagnosis and Surgical Resection 期刊论文
MOLECULAR PHARMACEUTICS, 2024, 页码: 1543-8392
作者:  Chao Li;  Changjian Li;  jian Zhou;  Yueqi Wang;  Hainan Wu,;  Luzheng Xu;  Yifeng Li;  Xizhao Sui;  Guanchao Jiang;  Yun Li;  Zhenhua Hu;  Jie Tian;  Fan Yang
Adobe PDF(8284Kb)  |  收藏  |  浏览/下载：13/4  |  提交时间：2024/06/11
Sensitive and quantitative in vivo analysis of PD‑L1 using magnetic particle imaging and imaging‑guided immunotherapy 期刊论文
European Journal of Nuclear Medicine and Molecular Imaging, 2022, 卷号: 50, 页码: 1291-1305
作者:  Zhengyao Peng;  Chang Lu;  Guangyuan Shi;  Lin Yin;  Xiaolong Liang;  Guosheng Song;  Jie Tian;  Yang Du
Adobe PDF(4924Kb)  |  收藏  |  浏览/下载：25/9  |  提交时间：2024/05/28
Deep learning for predicting immunotherapeutic efficacy in advanced non-small cell lung cancer patients: a retrospective study combining progression-free survival risk and overall survival risk 期刊论文
TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 页码: 23
作者:  He, Bing-Xi;  Zhong, Yi-Fan;  Zhu, Yong-Bei;  Deng, Jia-Jun;  Fang, Meng-Jie;  She, Yun-Lang;  Wang, Ting-Ting;  Yang, Yang;  Sun, Xi-Wen;  Belluomini, Lorenzo;  Watanabe, Satoshi;  Dong, Di;  Tian, Jie;  Xie, Dong
Adobe PDF(3742Kb)  |  收藏  |  浏览/下载：348/43  |  提交时间：2022/06/10
Tumor biomarkers  immunotherapy  lung neoplasms  programmed cell death 1 receptor (PD-1 receptor)  biostatistics  
Upfront dose-reduced chemotherapy synergizes with immunotherapy to optimize chemoimmunotherapy in squamous cell lung carcinoma 期刊论文
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 卷号: 8, 期号: 2, 页码: 15
作者:  He, Xiran;  Du, Yang;  Wang, Zhijie;  Wang, Xin;  Duan, Jianchun;  Wan, Rui;  Xu, Jiachen;  Zhang, Pei;  Wang, Di;  Tian, Yanhua;  Han, Jiefei;  Fei, Kailun;  Bai, Hua;  Tian, Jie;  Wang, Jie
收藏  |  浏览/下载：268/0  |  提交时间：2021/01/06
drug therapy  combination  immunotherapy  lung neoplasms  lymphocytes  tumor-infiltrating  translational medical research  
Assessing PD-L1 expression in non-small cell lung cancer and predicting responses to immune checkpoint inhibitors using deep learning on computed tomography images 期刊论文
Theranostics, 2020, 卷号: 0, 期号: 0, 页码: 0
作者:  Tian, Panwen;  He, Bingxi;  Dong, Di;  Mu, Wei;  Liu, Kunqin;  Liu, Li;  Zeng, Hao;  Liu, Yujie;  Jiang, Lili;  Zhou, Ping;  Huang, Zhipei;  Li, Weimin;  Tian, Jie
浏览  |  Adobe PDF(1539Kb)  |  收藏  |  浏览/下载：302/120  |  提交时间：2020/10/25
PD-L1 expression  deep learning  computed tomography  immunotherapy  non-small cell lung cancer.  
Construction of a novel bispecific fusion protein to enhance targeting for pancreatic cancer imaging 期刊论文
BIOMATERIALS, 2020, 期号: 255, 页码: 120161
作者:  Wang, Qian;  Yan, Hao;  Wang, Zihua;  Li, Zhangfu;  Li, Dan;  Li, Zheng;  Wang, Kun;  Tian, Jie;  Zhao, Xinming
浏览  |  Adobe PDF(3211Kb)  |  收藏  |  浏览/下载：324/62  |  提交时间：2020/09/07
Bispecific targeting  Fusion protein  Antibody  Molecular imaging  Pancreatic cancer  
Predicting response to immunotherapy in advanced non-small-cell lung cancer using tumor mutational burden radiomic biomarker 期刊论文
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 卷号: 8, 期号: 2, 页码: 10
作者:  He, Bingxi;  Dong, Di;  She, Yunlang;  Zhou, Caicun;  Fang, Mengjie;  Zhu, Yongbei;  Zhang, Henghui;  Huang, Zhipei;  Jiang, Tao;  Tian, Jie;  Chen, Chang
浏览  |  Adobe PDF(5232Kb)  |  收藏  |  浏览/下载：357/58  |  提交时间：2020/08/24
immunotherapy  lung neoplasms  tumor microenvironment  biomarkers  tumor  biostatistics  
Metal-Organic Frameworks as a Theranostic Nanoplatform for Combinatorial Chemophotothermal Therapy Adapted to Different Administration 期刊论文
ACS BIOMATERIALS SCIENCE & ENGINEERING, 2020, 卷号: 6, 期号: 2, 页码: 1008-1016
作者:  Shang, Wenting;  Peng, Li;  Guo, Pengyu;  Hui, Hui;  Yang, Xin;  Tian, Jie
浏览  |  Adobe PDF(1026Kb)  |  收藏  |  浏览/下载：403/93  |  提交时间：2020/04/07
metal-organic frameworks (MOFs)  intravenous injection  local instillation  photothermal therapy  combination therapy  
CT-Based Radiomic Signature as a Prognostic Factor in Stage IV ALK-Positive Non-small-cell Lung Cancer Treated With TKI Crizotinib: A Proof-of-Concept Study 期刊论文
FRONTIERS IN ONCOLOGY, 2020, 卷号: 10, 页码: 57
作者:  Li, Hailin;  Zhang, Rui;  Wang, Siwen;  Fang, Mengjie;  Zhu, Yongbei;  Hu, Zhenhua;  Dong, Di;  Shi, Jingyun;  Tian, Jie
Adobe PDF(915Kb)  |  收藏  |  浏览/下载：404/50  |  提交时间：2020/04/07
computed tomography  radiomics  non-small-cell lung cancer  tyrosine kinase inhibitor resistance  anaplastic lymphoma kinase  
Identification of HDAC9 as a viable therapeutic target for the treatment of gastric cancer 期刊论文
EXPERIMENTAL AND MOLECULAR MEDICINE, 2019, 卷号: 51, 页码: 15
作者:  Xiong, Kai;  Zhang, Hejun;  Du, Yang;  Tian, Jie;  Ding, Shigang
收藏  |  浏览/下载：239/0  |  提交时间：2019/12/16